A Phase Ib Study of Rezatapopt in Combination With Azacitidine in Patients With TP53Y220C Mutant Myeloid Malignancies (Acute Myeloid Leukemia or Myelodysplastic Syndrome)
Clinical trial NCT06616636 · RECRUITING
Trial details
- NCT number
- NCT06616636
- Sponsor
- M.D. Anderson Cancer Center
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-30
- Primary completion
- 2027-08-27
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.